Article
The relevance of soluble CD137 in the regulation of immune responses and for immunotherapeutic intervention
13 Feb 2020
Abstract excerpt
CD137 is a potent costimulatory receptor. Several agonistic anti-CD137 antibodies are currently in clinical trials for tumor immunotherapy. Soluble forms of CD137 (sCD137) are generated by differential splicing and antagonize the activities of membrane-bound CD137 (mCD137) and of therapeutic CD137 agonists. sCD137 is found in sera of patients suffering from autoimmune diseases where it is a natural regulator of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
